Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Poxel discloses new AMPK activators

Aug. 2, 2011

Lilly and Lupin enter collaboration for diabetes therapies

Aug. 1, 2011

Invaron Pharmaceuticals obtains license for Striant

Aug. 1, 2011

Reply submitted to FDA's complete response letter on Bydureon NDA

July 29, 2011

BioMarin reports preliminary results from phase I/II extension study of GALNS

July 29, 2011

Study investigates dyslipidemia-promoting mechanisms in obesity

July 29, 2011

New glucokinase activators patented by Advinus Therapeutics

July 28, 2011

New glucagon GLP1 receptor agonists presented by Novo Nordisk

July 28, 2011

New GPR119 receptor agonists described by Nippon Chemiphar

July 27, 2011

Takeda resubmits NDAs for two diabetes therapies

July 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...